Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$18.18
+2.36%
Mkt Cap $1.19B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (5 analysts)
$31.75
Range $22.00 – $37.00
Implied Upside
+74.6%
Consensus $31.75 vs current $18.18
NASDAQ·Healthcare·Biotechnology
$18.18
+2.36%
Mkt Cap $1.19B
Buy
6
Hold
0
Sell
0
Price Target (5 analysts)
$31.75
Range $22.00 – $37.00
+74.6%
Consensus $31.75 vs current $18.18